Webinar – The Impact of COVID-19 on Drug Diversion in Healthcare
- October 7, 2021
- 10:00am - 11:00am Pacific Time
- CHI owner insured hospital and long term care risk managers, patient safety officers, quality improvement, drug diversion specialists, pharmacy staff, direct care providers, clinical leadership, clinical educators.
Drug diversion didn’t disappear when the COVID-19 pandemic started in 2020. Many
changes associated with managing the COVID-19 pandemic may in fact be creating
new opportunities for drug diversion that could be difficult to detect if you don’t know
what you are looking for. The impact on staff, family, and the community has resulted in
an increase in mental health needs and substance use disorders. This webinar is
designed to help you identify ways to mitigate new diversion risk points and to be
prepared to help your staff and community cope.
- Identity one change in DEA rules due to COVID-19
- Describe at least two workflow changes during COVID-19 that created
unintended opportunities for diversion
- Relate human responses to COVID-19 and impact on rate of drug diversion in
- Evaluate 3 drug diversion risk mitigation strategies.
Provider approved by the California Board of Registered Nursing, Provider number 12205 for 1 contact hour.
Maureen Burger is the Chief Nursing Officer for Visante Consulting LLC, a medication management consulting firm. She has a long career in positions of progressive responsibility, both in nursing and hospital administration, most recently as the Vice President of Quality, Safety, Risk, Accreditation, and Infection Control for Indiana University Health. As a consultant, she is thrilled to be able to focus her research, writing, and consulting on medication safety, especially when it involves IV push medications and drug diversion in healthcare. Ms. Burger obtained a Master’s degree in Critical Care Nursing from Case Western Reserve University, is certified in Healthcare Quality, and is recognized as a Fellow by the American College of Healthcare Executives. She is the humble recipient of a Daisy Award. Maureen is a member of AONL, AACN, INS, NPSF, ACHE, and the IHFDA. She is a founding member of the National Coalition for IV Push Safety (www.ncivps.org ), and is a frequent speaker and author on topics related to medication safety and drug diversion.
When she is not advocating for patients and safety, Maureen, and her husband breed and race Thoroughbred horses. Ms. Burger lives in Indianapolis, IN.
The name “Visante” (Vee sahnt) was coined by our founder Mike Flagstad as a combination of the French words “vie” (life) and santé (health), a concept that directly aligns with the firm’s mission and philosophy.
Optima is using Zoom Webinars for this presentation. Upon registration, you will receive connection information with a unique link to join the webinar.
This event is a webinar. Optima is using Zoom Webinars for this presentation. Upon registration, you will receive connection information with a unique link to join the webinar.